Effects of dl-methylephedrine on cognitive functions in normal adults using fMRI: randomized, placebo-controlled, double-blind, comparative study
Not Applicable
- Conditions
- Healthy adults
- Registration Number
- JPRN-UMIN000024842
- Lead Sponsor
- ippon Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 29
Inclusion Criteria
Not provided
Exclusion Criteria
Subjects with drug allergy. Subjects taking drugs within 2 weeks of the trial. Subjects with hyperthyroidism, hypertension, heart disease, diabetes, severe asthma or hypoxemia. Pregnant woman, woman suspected of being pregnant, or lactating woman. Subject who is contraindicated for the use of MRI. Subjects taking caffeine 2 days before or alcohol the day before the trial. Subjects who are judged as not suitable for participation in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method BOLD signal changes measured by fMRI
- Secondary Outcome Measures
Name Time Method